Pharmaceutical company Forest Laboratories (FRX) announced plans on Monday to streamline operations in a bid to save money, while also saying that it is aiming to bolster sales by buying the U.S.

MONTPELIER – The letter begins with pure flattery. "As a recognized thought leader and well-respected health care professional among your peers, we are seeking your participation as a speaker in our ...

WASHINGTON, July 30 (Reuters) - A U.S. medical advisory panel on Thursday widely supported Schering-Plough Corp's experimental drug, Saphris, as a safe and effective therapy for adults with acute ...